| |
Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be Held on January 20, 2023. The proxy materials are available at
https://jaguarhealth.gcs-web.com/financial-information/annual-reports |
| |
Name and address of beneficial owner
|
| |
Number
of Shares Beneficially Owned |
| |
Percentage
of Shares Beneficially Owned |
| ||||||
5% Stockholders: | | | | | | | | | | | | | |
Streeterville Capital LLC and Iliad Research and Trading L.P.(1)
|
| | | | 14,555,582 | | | | | | 9.6% | | |
Josh Mailman(2)
|
| | | | 8,614,138 | | | | | | 5.7% | | |
Named executive officers and directors: | | | | | | | | | | | | | |
Lisa A. Conte(3)
|
| | | | 600,463 | | | | | | * | | |
Steven R. King, Ph.D.(4)
|
| | | | 187,551 | | | | | | * | | |
Jonathan S. Wolin(5)
|
| | | | 143,044 | | | | | | * | | |
Ian Wendt(6)
|
| | | | 81,203 | | | | | | * | | |
James J. Bochnowski(7)
|
| | | | 365,611 | | | | | | * | | |
Jonathan B. Siegel(8)
|
| | | | 126,831 | | | | | | * | | |
John Micek III(9)
|
| | | | 74,042 | | | | | | * | | |
Anula Jayasuriya(10)
|
| | | | — | | | | | | * | | |
All current executive officers and directors as a group (8 persons)(11)
|
| | | | 1,578,745 | | | | | | 1.0% | | |
SERIES F PREFERRED STOCK
|
| ||||||||||||
Name of Beneficial Owner
|
| |
Number of Shares of
Series F Preferred Stock |
| |
Percentage
Ownership |
| ||||||
SynWorld Technologies Corporation(a)
|
| | | | Ten | | | | | | 100% | | |